By Thomas F LüscherTaken directly from the European Heart Journal. Well, wine is truly a joy, but at best neutral when consumed in moderation. Chocolate…View More Are wine, chocolate, coffee: forbidden joys?
Results from semi-structured interviews By Maarten Falter et alTaken directly from: European Heart Journal Digital Health While many trials have investigated telerehabilitation, few have studied…View More Are patients willing to participate in cardiac telerehabilitation?
By Ahmed El-Medany This prospective study by Sung et al assessed the relationship between physical activity (PA) and the development of coronary artery calcification (CAC).…View More Physical activity associated with progression of coronary artery calcification
By Ahmed El-Medany This research by Shenoy et al included 903 individuals undergoing CMRI for suspected cardiac tumour. The cardiac MRI diagnosis of ‘no mass’…View More Cardiac MRI key diagnostic tool in suspected cardiac tumour, predictive of prognosis
By Ahmed El-Medany A study by Schrage et al assessed 12,164 individuals from 3 European population-based cohorts. Absolute iron deficiency was defined as a ferritin…View More Iron deficiency linked with development of coronary artery disease
By Ahmed El-Medany Presented by Dr. Chiriacò at the American Heart Association’s Hypertension Scientific Sessions, a prospective study including 349 diabetic participants assessed the long-term…View More Nocturnal increase in blood pressure associated with increased mortality in diabetics
By Ahmed El-Medany Presented at ESC 2021 by Dr. Judit Simon, of the Heart and Vascular Centre, Semmelweis University, Budapest, Hungary; this large study included…View More A coffee a day keeps the doctor away?
By Ahmed El-Medany Treatment with a ‘quadpill’ containing quarter doses of four antihypertensive drugs demonstrated better blood pressure control than initial monotherapy with full-dose irbesartan,…View More Polypill beats monotherapy for hypertension: results from the QUARTET stud
Taken directly from JACC Over the last 4 decades, percutaneous coronary intervention has evolved dramatically and is now an acceptable treatment option for patients with…View More Percutaneous Coronary Revascularisation: Historical Breakthroughs
By Ahmed El-Medany One of the most popular sessions every year, an excellent variety of trials were presented at the 2021 BCS Annual Conference. For…View More In case you missed it: a summary of the BCS ’21 top 10 trials (Part II)